
Brii Biosciences Ltd
HKEX:2137

Fundamental Analysis


Revenue & Expenses Breakdown
Brii Biosciences Ltd
Balance Sheet Decomposition
Brii Biosciences Ltd
Current Assets | 2.4B |
Cash & Short-Term Investments | 2.3B |
Other Current Assets | 93.8m |
Non-Current Assets | 292.5m |
Long-Term Investments | 9.2m |
PP&E | 14.3m |
Intangibles | 179.7m |
Other Non-Current Assets | 89.3m |
Free Cash Flow Analysis
Brii Biosciences Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Brii Biosciences Ltd
Revenue
|
0
CNY
|
Operating Expenses
|
-382.4m
CNY
|
Operating Income
|
-382.4m
CNY
|
Other Expenses
|
-125.7m
CNY
|
Net Income
|
-508.2m
CNY
|
Profitability Score
Profitability Due Diligence
Brii Biosciences Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Brii Biosciences Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Brii Biosciences Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Brii Biosciences Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Brii Biosciences Ltd
According to Wall Street analysts, the average 1-year price target for
Brii Biosciences Ltd
is 1.02 HKD
with a low forecast of 1.01 HKD and a high forecast of 1.05 HKD.
Dividends
Current shareholder yield for Brii Biosciences Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?